Eric Mindich’s Eton Park Capital enjoyed a strong first quarter of 2015 according to our returns metric.
Keep Reading →
April 9 - Hedge Funds, News - Comments
John Paulson's Paulson & Co has been having it rough for the past two years, as far as stock picking goes.
Keep Reading →
February 20 - Hedge Funds, News - Comments
David Abrams’ Abrams Capital Management revealed its top five picks at the end of 2014 in its latest 13F filing. According to the information provided to the U.S.
Keep Reading →
February 17 - Hedge Funds, News - Comments
Rail-Splitter Capital Management, managed by John Croghan and Richard Fradin, recently filed its 13F Form with the U.S.
Keep Reading →
January 21 - Hedge Funds, News - Comments
In its latest 13F filing with the U.S.
Keep Reading →
August 18 - Hedge Funds, News - Comments
In its recent 13F filing with the U.S.
Keep Reading →
July 23 - Hedge Funds, News - Comments
Zug, Switzerland-based Argentiere Capital is an alternative investment management firm, which was founded by Deepak Gulati. Mr.
Keep Reading →
July 16 - Hedge Funds, News - Comments
St. Jude Medical, Inc. (NYSE:STJ) has been nothing short of great for investors this year, rewarding shareholders with stock gains of 40% since the start of 2013.
Keep Reading →
September 3 - News - Comments
In the 21st century investor’s toolkit, there are many indicators shareholders can use to track their holdings.
Keep Reading →
August 23 - News - Comments
To many traders, hedge funds are perceived as delayed, outdated investment tools of a forgotten age.
Keep Reading →
August 22 - News - Comments
In the financial world, there are plenty of indicators investors can use to watch Mr. Market. A pair of the most innovative are hedge fund and insider trading activity.
Keep Reading →
August 22 - News - Comments
The stock is up nearly 23% this year, even while companies like Johnson & Johnson (NYSE:JNJ) have disclosed lower-than-expected growth in surgical procedures.
Keep Reading →
August 7 - News - Comments
Abbott Laboratories (NYSE:ABT)' bid to acquire IDEV Technologies by end-2013 will strengthen the former’s medical devices (Abbott Vascular) business especially in stent offerings...
Keep Reading →
July 29 - News - Comments
The U.S. is the world’s leading medical device manufacture. Becton, Dickinson and Co. (NYSE:BDX), Baxter International Inc.
Keep Reading →
July 15 - News - Comments
After nearly two years of waiting, Covidien plc (NYSE:COV) investors were finally treated to the latest in a long line of pharmaceutical and medical device spin-offs.
Keep Reading →
July 11 - News - Comments
Leon Cooperman, the founder and chairman of Omega Advisors, is a very successful value investor.
Keep Reading →
May 29 - Hedge Funds - Comments
If you'd ask most investors, hedge funds are viewed as slow, old investment tools of the past.
Keep Reading →
May 24 - News - Comments
Editor's Note: Related tickers: Aon PLC (NYSE:AON), Marsh & McLennan Companies, Inc.
Keep Reading →
May 17 - Hedge Funds - Comments
A leading medical technology company, Becton, Dickinson and Co. (NYSE:BDX)'s earnings were better than expected.
Keep Reading →
May 14 - News - Comments
Cardiology device makers haven't had much good to report to investors lately.
Keep Reading →
May 9 - News - Comments
One of the peculiar aspects of the market move upwards in 2013 is that the defensives have led the way while the traditionally more economically sensitive areas like technology...
Keep Reading →
April 29 - News - Comments
There are several factors that could hurt other stocks that shouldn't be an issue for Johnson & Johnson (NYSE:JNJ). For example.
Keep Reading →
April 11 - News - Comments
Dublin-based pharmaceutical and medical device company Covidien plc (NYSE:COV) recently announced that it had authorized a share buyback program that could be worth up to $2...
Keep Reading →
April 2 - News - Comments
To the average investor, there are dozens of methods shareholders can use to monitor the equity markets.
Keep Reading →
March 27 - News - Comments
Funnily enough, I think that long term investors should be investing in the long term.
Keep Reading →
March 19 - News - Comments
Dublin-based medical conglomerate Covidien PLC (NYSE:COV) has confirmed that it plans to complete the spin-off of its pharmaceutical division by the middle of 2013.
Keep Reading →
March 19 - News - Comments
Shares of Johnson & Johnson (NYSE:JNJ) have climbed 16% over the past five months and as of this writing, the stock is making new 52-week highs.
Keep Reading →
March 18 - News - Comments
It’s the start of a new month and time to review quarterly performance and more importantly whether the process of writing investment thoughts out here and on my blog is helping...
Keep Reading →
March 5 - News - Comments
Occasionally some of my friends ask me why I am hedged and market neutral in my investing. My answer is always the same.
Keep Reading →
February 22 - News - Comments
Are you ready for another health-care spinoff? Investors experienced two already in 2013 -- and we're barely into the second month of the year.
Keep Reading →
February 6 - News - Comments
Intuitive Surgical, Inc. (NASDAQ:ISRG), appears to be amongst todays best examples of how to separate a great company from a great investment.
Keep Reading →
February 4 - News - Comments
It's February, and I've surprisingly managed to stick with my New Year's resolution.
Keep Reading →
February 1 - News - Comments